These findings suggest crosstalk among stress response signaling pathways, with HSF1 driving chemoresistance through mechanisms like ER stress via PERK and HIF-1α signaling, ultimately enhancing cancer cell survival during chemotherapy. Here, HSF1 is linked to cancer.